Hepatitis B virus - recent therapeutic advances and challenges to cure

J Hepatol. 2020 Sep;73(3):694-695. doi: 10.1016/j.jhep.2020.04.015. Epub 2020 Jul 16.

Authors

Karim Mouzannar¹, T Jake Liang²

Affiliations

¹ Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, 20892, USA.
² Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, 20892, USA. Electronic address: jakel@bdg10.niddk.nih.gov.

PMID: 32682539
DOI: 10.1016/j.jhep.2020.04.015

No abstract available

Keywords: Advances; Clinical phase; Direct-acting antivirals; Drug; Functional cure; HBV.

Publication types

Research Support, N.I.H., Intramural
Research Support, Non-U.S. Gov't

MeSH terms

Antiviral Agents / pharmacology
Antiviral Agents / therapeutic use*
DNA, Viral / blood
Hepatitis Antibodies / blood
Hepatitis B Surface Antigens / immunology
Hepatitis B virus / drug effects
Hepatitis B virus / genetics*
Hepatitis B virus / immunology*
Hepatitis B, Chronic / blood
Hepatitis B, Chronic / drug therapy*
Hepatitis B, Chronic / immunology*
Humans
Treatment Outcome

Substances

Antiviral Agents
DNA, Viral
Hepatitis Antibodies
Hepatitis B Surface Antigens